EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access

A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity

Kenta Matsuda, Stephen A Migueles, Jinghe Huang, Lyuba Bolkhovitinov, Sarah Stuccio, Trevor Griesman, Alyssa A Pullano, Byong H Kang, Elise Ishida, Matthew Zimmerman, Neena Kashyap, Kelly M Martins und 16 weitere

Journal of Clinical Investigation · 01.03.2021 · 131 (5)

DOI: 10.1172/jci140794 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.03.2021. Verfasst von Kenta Matsuda und 27 weiteren Autor:innen. Beteiligte Einrichtung: HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Ma…. Hauptthemen laut MEDLINE: Genetic Vectors. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Centers of Influenza Virus Research and Surveillance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic VectorsAdenoviruses, HumanAdministration, OralAdolescentAdultAntibodies, NeutralizingAntibodies, ViralAntigens, ViralFemaleHemagglutinin Glycoproteins, Influenza VirusHumansImmunity, CellularImmunity, HumoralImmunity, MucosalInfluenza A Virus, H5N1 SubtypeInfluenza VaccinesInfluenza, HumanMaleNasal SpraysPalatine TonsilVirus Replication

Stichwörter der Autor:innen

Adaptive immunityBeta cellsImmunologyInfluenzaVaccines

Substanzen

Antibodies, NeutralizingAntibodies, ViralAntigens, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesNasal Sprayshemagglutinin, avian influenza A virus

Autor:innen und Institutionen

  • HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Biostatistics Research Branch, NIAID and.
  • Trans-NIH Center for Human Immunology, Autoimmunity, and Inflammation, NIH, Bethesda, Maryland, USA.
  • Emergent Biosolutions Inc., Gaithersburg, Maryland, USA.

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • Centers of Influenza Virus Research and Surveillance
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Matsuda, K., Migueles, S. A., Huang, J., Bolkhovitinov, L., Stuccio, S., Griesman, T., Pullano, A. A., Kang, B. H., Ishida, E., Zimmerman, M., Kashyap, N., Martins, K. M., Stadlbauer, D., Pederson, J., Patamawenu, A., Wright, N., Shofner, T., Evans, S., Liang, C. J., …, & Connors, M. (2021). A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity. Journal of Clinical Investigation, 131(5). https://doi.org/10.1172/jci140794

Vancouver

Matsuda K, Migueles SA, Huang J, Bolkhovitinov L, Stuccio S, Griesman T, et al. A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity. Journal of Clinical Investigation. 2021;131(5). doi:10.1172/jci140794

BibTeX
@article{Matsuda2021,
  author = {Matsuda, Kenta and Migueles, Stephen A and Huang, Jinghe and Bolkhovitinov, Lyuba and Stuccio, Sarah and Griesman, Trevor and Pullano, Alyssa A and Kang, Byong H and Ishida, Elise and Zimmerman, Matthew and Kashyap, Neena and Martins, Kelly M and Stadlbauer, Daniel and Pederson, Jessica and Patamawenu, Andy and Wright, Nathaniel and Shofner, Tulley and Evans, Sean and Liang, C Jason and Candia, Julián and Biancotto, Angelique and Fantoni, Giovanna and Poole, April and Smith, Jon and Alexander, Jeff and Gurwith, Marc and Krammer, Florian and Connors, Mark},
  title = {A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  volume = {131},
  number = {5},
  doi = {10.1172/jci140794}
}
Kostenlos starten →